Cargando…

Plasma Levels of Apelinergic System Components in Patients with Chronic and Acute Coronary Syndromes—A Pilot Study

The effects of the apelinergic system components apelin (AP) and elabela (ELA) in the regulation of human cardiovascular homeostasis, and data concerning the relationship between ELA and AP and coronary artery disease (CAD) are yet unknown. The aim of the study was the evaluation of AP, ELA and APJ-...

Descripción completa

Detalles Bibliográficos
Autores principales: Diakowska, Dorota, Wyderka, Rafal, Krzystek-Korpacka, Małgorzata, Osuch, Łukasz, Leśków, Anna, Sołtowska, Alicja, Stanek, Marta, Rosińczuk, Joanna, Jaroch, Joanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509670/
https://www.ncbi.nlm.nih.gov/pubmed/34640437
http://dx.doi.org/10.3390/jcm10194420
_version_ 1784582398404460544
author Diakowska, Dorota
Wyderka, Rafal
Krzystek-Korpacka, Małgorzata
Osuch, Łukasz
Leśków, Anna
Sołtowska, Alicja
Stanek, Marta
Rosińczuk, Joanna
Jaroch, Joanna
author_facet Diakowska, Dorota
Wyderka, Rafal
Krzystek-Korpacka, Małgorzata
Osuch, Łukasz
Leśków, Anna
Sołtowska, Alicja
Stanek, Marta
Rosińczuk, Joanna
Jaroch, Joanna
author_sort Diakowska, Dorota
collection PubMed
description The effects of the apelinergic system components apelin (AP) and elabela (ELA) in the regulation of human cardiovascular homeostasis, and data concerning the relationship between ELA and AP and coronary artery disease (CAD) are yet unknown. The aim of the study was the evaluation of AP, ELA and APJ-receptor levels in the plasma of patients with chronic coronary syndromes (CCS) and acute coronary syndromes (ACS). The study group consisted of 114 patients with CAD and 33 healthy controls. Patients were divided into two groups: with CCS (n = 30) and ACS (n = 84). Routine laboratory tests and plasma ELA, AP-17, AP-13 and APJ receptor levels were measured. Echocardiographic data were analyzed in all patients. Levels of AP-17 and ELA were significantly lower in CCS than in healthy controls and ACS patients. We demonstrated significant increase of levels of plasma apelinergic system peptides, especially ELA and AP-17 in ACS patients compared with healthy controls and CCS, suggestive of compensating up-regulation mechanisms. There is a relationship between circulating ELA and AP-17 levels and classical, biochemical markers of ischemia and left ventricular ejection faction as well.
format Online
Article
Text
id pubmed-8509670
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-85096702021-10-13 Plasma Levels of Apelinergic System Components in Patients with Chronic and Acute Coronary Syndromes—A Pilot Study Diakowska, Dorota Wyderka, Rafal Krzystek-Korpacka, Małgorzata Osuch, Łukasz Leśków, Anna Sołtowska, Alicja Stanek, Marta Rosińczuk, Joanna Jaroch, Joanna J Clin Med Article The effects of the apelinergic system components apelin (AP) and elabela (ELA) in the regulation of human cardiovascular homeostasis, and data concerning the relationship between ELA and AP and coronary artery disease (CAD) are yet unknown. The aim of the study was the evaluation of AP, ELA and APJ-receptor levels in the plasma of patients with chronic coronary syndromes (CCS) and acute coronary syndromes (ACS). The study group consisted of 114 patients with CAD and 33 healthy controls. Patients were divided into two groups: with CCS (n = 30) and ACS (n = 84). Routine laboratory tests and plasma ELA, AP-17, AP-13 and APJ receptor levels were measured. Echocardiographic data were analyzed in all patients. Levels of AP-17 and ELA were significantly lower in CCS than in healthy controls and ACS patients. We demonstrated significant increase of levels of plasma apelinergic system peptides, especially ELA and AP-17 in ACS patients compared with healthy controls and CCS, suggestive of compensating up-regulation mechanisms. There is a relationship between circulating ELA and AP-17 levels and classical, biochemical markers of ischemia and left ventricular ejection faction as well. MDPI 2021-09-26 /pmc/articles/PMC8509670/ /pubmed/34640437 http://dx.doi.org/10.3390/jcm10194420 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Diakowska, Dorota
Wyderka, Rafal
Krzystek-Korpacka, Małgorzata
Osuch, Łukasz
Leśków, Anna
Sołtowska, Alicja
Stanek, Marta
Rosińczuk, Joanna
Jaroch, Joanna
Plasma Levels of Apelinergic System Components in Patients with Chronic and Acute Coronary Syndromes—A Pilot Study
title Plasma Levels of Apelinergic System Components in Patients with Chronic and Acute Coronary Syndromes—A Pilot Study
title_full Plasma Levels of Apelinergic System Components in Patients with Chronic and Acute Coronary Syndromes—A Pilot Study
title_fullStr Plasma Levels of Apelinergic System Components in Patients with Chronic and Acute Coronary Syndromes—A Pilot Study
title_full_unstemmed Plasma Levels of Apelinergic System Components in Patients with Chronic and Acute Coronary Syndromes—A Pilot Study
title_short Plasma Levels of Apelinergic System Components in Patients with Chronic and Acute Coronary Syndromes—A Pilot Study
title_sort plasma levels of apelinergic system components in patients with chronic and acute coronary syndromes—a pilot study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509670/
https://www.ncbi.nlm.nih.gov/pubmed/34640437
http://dx.doi.org/10.3390/jcm10194420
work_keys_str_mv AT diakowskadorota plasmalevelsofapelinergicsystemcomponentsinpatientswithchronicandacutecoronarysyndromesapilotstudy
AT wyderkarafal plasmalevelsofapelinergicsystemcomponentsinpatientswithchronicandacutecoronarysyndromesapilotstudy
AT krzystekkorpackamałgorzata plasmalevelsofapelinergicsystemcomponentsinpatientswithchronicandacutecoronarysyndromesapilotstudy
AT osuchłukasz plasmalevelsofapelinergicsystemcomponentsinpatientswithchronicandacutecoronarysyndromesapilotstudy
AT leskowanna plasmalevelsofapelinergicsystemcomponentsinpatientswithchronicandacutecoronarysyndromesapilotstudy
AT sołtowskaalicja plasmalevelsofapelinergicsystemcomponentsinpatientswithchronicandacutecoronarysyndromesapilotstudy
AT stanekmarta plasmalevelsofapelinergicsystemcomponentsinpatientswithchronicandacutecoronarysyndromesapilotstudy
AT rosinczukjoanna plasmalevelsofapelinergicsystemcomponentsinpatientswithchronicandacutecoronarysyndromesapilotstudy
AT jarochjoanna plasmalevelsofapelinergicsystemcomponentsinpatientswithchronicandacutecoronarysyndromesapilotstudy